Annelisa S A C Santos1, Ana Paula S Rodrigues2, Lorena P S Rosa2, Nizal Sarrafzadegan3, Erika A Silveira2. 1. Programa de Pós-Graduação em Ciências da Saúde, Faculdade de Medicina, Universidade Federal de Goiás, Brazil. Electronic address: annelisa.nut@gmail.com. 2. Programa de Pós-Graduação em Ciências da Saúde, Faculdade de Medicina, Universidade Federal de Goiás, Brazil. 3. Isfahan Cardiovascular Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran; School of Population and Public Health, Faculty of Medicine, University of British Columbia, Vancouver, Canada.
Abstract
BACKGROUND AND AIMS: Little is known about differences of cardiometabolic risk factors (CMRF) and the function of Framingham Risk Score (FRS) within severe obesity, thus we aimed to study not only CMRF and FRS, but to determine significant differences between BMI ranges within severe obesity. METHODS AND RESULTS: In this baseline analysis of the Traditional Brazilian Diet (DieTBra) Trial, several CMRF were assessed in 150 adult patients in two BMI ranges: 35.0-44.9 kg/m2 (n = 76) and ≥45 kg/m2 (n = 74). Body composition was evaluated by multifrequency bioelectrical impedance analysis to measure the percent of body fat, visceral fat area and waist circumference. Pearson's Chi-squared, Fisher's Exact, Student's t-test, and Mann-Whitney's test were used in the statistical analysis with a 5% significance level. Hypertension, C-reactive protein, systolic and diastolic blood pressure and positive family history for heart diseases were more prevalent in BMI ≥45.0 kg/m2 (p < 0.05). Mean values of waist circumference, body fat %, visceral fat area, and systolic blood pressure were significantly higher in patients with BMI ≥45.0 kg/m2. Regarding the function of FRS, 40.0% of the patients were at high risk. No differences were found for diabetes, lifestyle, lipid parameters, and FRS within different BMI ranges, except for dyslipidemia, significantly higher among participants with BMI 35.0-44.9 kg/m2. CONCLUSION: BMI >45 kg/m2 was associated with higher prevalence of hypertension, systolic and diastolic blood pressure, C-reactive protein, waist circumference, body fat % and family history of heart diseases, enhancing the risk for the occurrence of cardiovascular diseases.
BACKGROUND AND AIMS: Little is known about differences of cardiometabolic risk factors (CMRF) and the function of Framingham Risk Score (FRS) within severe obesity, thus we aimed to study not only CMRF and FRS, but to determine significant differences between BMI ranges within severe obesity. METHODS AND RESULTS: In this baseline analysis of the Traditional Brazilian Diet (DieTBra) Trial, several CMRF were assessed in 150 adult patients in two BMI ranges: 35.0-44.9 kg/m2 (n = 76) and ≥45 kg/m2 (n = 74). Body composition was evaluated by multifrequency bioelectrical impedance analysis to measure the percent of body fat, visceral fat area and waist circumference. Pearson's Chi-squared, Fisher's Exact, Student's t-test, and Mann-Whitney's test were used in the statistical analysis with a 5% significance level. Hypertension, C-reactive protein, systolic and diastolic blood pressure and positive family history for heart diseases were more prevalent in BMI ≥45.0 kg/m2 (p < 0.05). Mean values of waist circumference, body fat %, visceral fat area, and systolic blood pressure were significantly higher in patients with BMI ≥45.0 kg/m2. Regarding the function of FRS, 40.0% of the patients were at high risk. No differences were found for diabetes, lifestyle, lipid parameters, and FRS within different BMI ranges, except for dyslipidemia, significantly higher among participants with BMI 35.0-44.9 kg/m2. CONCLUSION: BMI >45 kg/m2 was associated with higher prevalence of hypertension, systolic and diastolic blood pressure, C-reactive protein, waist circumference, body fat % and family history of heart diseases, enhancing the risk for the occurrence of cardiovascular diseases.
Authors: Erika Aparecida Silveira; Jacqueline Danesio de Souza; Annelisa Silva E Alves de Carvalho Santos; Andrea Batista de Souza Canheta; Valéria Pagotto; Matias Noll Journal: Arch Public Health Date: 2020-08-03
Authors: Carolina Rodrigues Mendonça; Matias Noll; Annelisa Silva E Alves de Carvalho Santos; Ana Paula Dos Santos Rodrigues; Erika Aparecida Silveira Journal: Korean J Pain Date: 2020-07-01
Authors: Erika Aparecida Silveira; Jacqueline Danésio de Souza; Ana Paula Dos Santos Rodrigues; Ricardo M Lima; Camila Kellen de Souza Cardoso; Cesar de Oliveira Journal: Nutrients Date: 2020-05-21 Impact factor: 5.717
Authors: Erika Aparecida Silveira; Annelisa Silva E Alves de Carvalho Santos; Jessivane Nascimento Ribeiro; Matias Noll; Ana Paula Dos Santos Rodrigues; Cesar de Oliveira Journal: BMC Gastroenterol Date: 2021-05-12 Impact factor: 3.067
Authors: Rafael Longhi; Annelisa Silva E Alves de Carvalho Santos; Anallely López-Yerena; Ana Paula Santos Rodrigues; Cesar de Oliveira; Erika Aparecida Silveira Journal: Nutrients Date: 2021-11-19 Impact factor: 5.717
Authors: Camila Kellen de Souza Cardoso; Maria do Rosário Gondim Peixoto; Ana Paula Dos Santos Rodrigues; Carolina Rodrigues Mendonça; Cesar de Oliveira; Erika Aparecida Silveira Journal: Int J Environ Res Public Health Date: 2020-09-25 Impact factor: 3.390
Authors: Erika Aparecida Silveira; Camila Kellen de Souza Cardoso; Letícia de Almeida Nogueira E Moura; Ana Paula Dos Santos Rodrigues; Cesar de Oliveira Journal: Nutrients Date: 2021-06-22 Impact factor: 5.717